Sabra Healthcare REIT (NASDAQ:SBRA) Upgraded by Truist Financial to “Buy” Rating

Sabra Healthcare REIT (NASDAQ:SBRA) was upgraded by stock analysts at Truist Financial from a “hold” rating to a “buy” rating in a report released on Wednesday,Benzinga reports. The firm currently has a $22.00 price objective on the real estate investment trust’s stock. Truist Financial’s target price suggests a potential upside of 9.67% from the company’s current price.

Several other research firms have also recently commented on SBRA. Wells Fargo & Company raised their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Raymond James Financial started coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating for the company. Barclays assumed coverage on shares of Sabra Healthcare REIT in a report on Tuesday. They set an “overweight” rating and a $21.00 price target on the stock. Finally, Scotiabank dropped their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Six research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Sabra Healthcare REIT has an average rating of “Hold” and an average target price of $21.27.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA opened at $20.06 on Wednesday. The company’s fifty day moving average is $19.70 and its two-hundred day moving average is $19.68. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $21.28. The company has a market cap of $5.06 billion, a P/E ratio of 31.84, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. During the same period last year, the company posted $0.37 EPS. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts expect that Sabra Healthcare REIT will post 1.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of SBRA. Vanguard Group Inc. boosted its holdings in Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after purchasing an additional 481,231 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Sabra Healthcare REIT by 0.4% during the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after buying an additional 98,770 shares in the last quarter. Nuveen LLC lifted its position in shares of Sabra Healthcare REIT by 28.6% in the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after buying an additional 1,625,072 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Sabra Healthcare REIT by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock worth $132,949,000 after buying an additional 198,118 shares during the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after acquiring an additional 447,528 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.